Prednicarbate Overview Categories 18 Hormones and other endocrine drugs and contraceptives18.1 Corticosteroids, systemic Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Prednicarbate Manufacturers of Prednicarbate Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Prednicarbate's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.1 %0.1 (0.1)24 hourlyTopical0.1% may be used with caution in pediatric patients 1 year of age or older. The safety and efficacy of drug use for longer than 3 weeks in this population have not been established. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Prednicarbate is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Prednicarbate is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Prednicarbate Back to top Manufacturers of Prednicarbate in Pakistan GSK Tabros Back to top Previous Drug Generic - Next Drug Generic
Prednicarbate Overview Categories 18 Hormones and other endocrine drugs and contraceptives18.1 Corticosteroids, systemic Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Prednicarbate Manufacturers of Prednicarbate Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Prednicarbate's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.1 %0.1 (0.1)24 hourlyTopical0.1% may be used with caution in pediatric patients 1 year of age or older. The safety and efficacy of drug use for longer than 3 weeks in this population have not been established. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Prednicarbate is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Prednicarbate is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Prednicarbate Back to top Manufacturers of Prednicarbate in Pakistan GSK Tabros Back to top Previous Drug Generic - Next Drug Generic